Invasive Aspergillus infections in hematologic malignancy patients.
about
Invasive aspergillosis due to Neosartorya udagawaeEvaluation of lysine biosynthesis as an antifungal drug target: biochemical characterization of Aspergillus fumigatus homocitrate synthase and virulence studiesCharacterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.The small GTPase RacA mediates intracellular reactive oxygen species production, polarized growth, and virulence in the human fungal pathogen Aspergillus fumigatus.Biomarkers for invasive aspergillosis: the challenges continue.Efficacy of caspofungin against Aspergillus flavus, Aspergillus terreus, and Aspergillus nidulansComparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosisMycological Microscopic and Culture Examination of 400 Bronchoalveolar Lavage (BAL) Samples.Disruption of the Aspergillus fumigatus gene encoding nucleolar protein CgrA impairs thermotolerant growth and reduces virulence.Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatusAdvances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders.Evaluating the role of prophylaxis in the management of invasive fungal infections in patients with hematologic malignancy.In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.
P2860
Q33909352-E8159FA6-3AD9-4F37-9E91-442B356FB95DQ33983108-C3184408-9093-4025-99BB-26D8144E9A4FQ34719835-C61C6000-E25D-43AC-B8B9-74FC8D88BFA7Q34739183-D702102E-8933-484F-9D3B-E09418C3648CQ35142428-40F6DBB6-F737-4A1C-AB26-4116974C02A1Q35215384-ABC004A6-1797-4517-9475-975BA2205482Q35636789-1CF6267C-CFB7-4A26-8481-21589B56800EQ36310961-91FBE510-7631-4975-942B-2C477B3DE8DCQ36443838-A152E0EC-FFFD-43C1-A370-8BC517B0E4E2Q36702963-58309866-5D3A-49E3-A0C3-5F45C83EFEF7Q36774247-F7147677-306D-4AED-AA2B-5F87FCDDF633Q37900678-87576B29-DD3D-4519-9A76-0B42D37CFB4DQ39743420-8AEB0F90-1DE2-43B8-A7AB-AE396A010EE4Q39954754-D5691085-586B-4D19-A6B5-0AB032FDF91AQ44023091-4F73BC68-A1D4-49E8-BF56-88650CD83E8E
P2860
Invasive Aspergillus infections in hematologic malignancy patients.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Invasive Aspergillus infections in hematologic malignancy patients.
@ast
Invasive Aspergillus infections in hematologic malignancy patients.
@en
Invasive Aspergillus infections in hematologic malignancy patients.
@nl
type
label
Invasive Aspergillus infections in hematologic malignancy patients.
@ast
Invasive Aspergillus infections in hematologic malignancy patients.
@en
Invasive Aspergillus infections in hematologic malignancy patients.
@nl
prefLabel
Invasive Aspergillus infections in hematologic malignancy patients.
@ast
Invasive Aspergillus infections in hematologic malignancy patients.
@en
Invasive Aspergillus infections in hematologic malignancy patients.
@nl
P356
P1476
Invasive Aspergillus infections in hematologic malignancy patients.
@en
P2093
Sofia Perea
Thomas F Patterson
P304
P356
10.1053/SRIN.2002.33443
P577
2002-06-01T00:00:00Z